Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hilton

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Synapse (New York, N.Y.)|January 7, 2012
Correlation of the vesicular acetylcholine transporter densities in the striata to the clinical abilities of women with Rett syndromeJames Robert Brašić, Genila Bibat, Anil Kumar, et al.
Nuclear Medicine and Biology|December 27, 2007
In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PETPeter S Conti, James R Bading, Peter P Mouton, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort StudyArif Ali Awan, Deanna Saunders, Gregory Pond, et al.
Journal of Medicinal Chemistry|July 9, 2008
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propertiesYongjun Gao, Hiroto Kuwabara, Charles E Spivak, et al.
Breast Cancer Research and Treatment|May 26, 2019
Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)Bassam Basulaiman, Arif Ali Awan, Dean Fergusson, et al.
Clinical Breast Cancer|August 25, 2016
Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic ReviewShaan Dudani, Sasha Mazzarello, John Hilton, et al.
Journal of Bone Oncology|June 24, 2016
Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)Ricardo Fernandes, Peter Siegel, Svetlana Komarova, et al.
CNS Neuroscience & Therapeutics|June 21, 2018
A cholecystokinin B receptor antagonist and cocaine interaction, phase I studyAhmed Elkashef, James Robert Brašić, Louis R Cantelina, et al.
Bioorganic & Medicinal Chemistry|June 2, 2009
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomographyYongjun Gao, Hayden T Ravert, Hiroto Kuwabara, et al.
NEJM Evidence|May 26, 2026
Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast CancerMark Clemons, Carol Stober, Gregory R Pond, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Synapse (New York, N.Y.)|January 7, 2012
Correlation of the vesicular acetylcholine transporter densities in the striata to the clinical abilities of women with Rett syndromeJames Robert Brašić, Genila Bibat, Anil Kumar, et al.
Nuclear Medicine and Biology|December 27, 2007
In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PETPeter S Conti, James R Bading, Peter P Mouton, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort StudyArif Ali Awan, Deanna Saunders, Gregory Pond, et al.
Journal of Medicinal Chemistry|July 9, 2008
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propertiesYongjun Gao, Hiroto Kuwabara, Charles E Spivak, et al.
Breast Cancer Research and Treatment|May 26, 2019
Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)Bassam Basulaiman, Arif Ali Awan, Dean Fergusson, et al.
Clinical Breast Cancer|August 25, 2016
Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic ReviewShaan Dudani, Sasha Mazzarello, John Hilton, et al.
Journal of Bone Oncology|June 24, 2016
Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)Ricardo Fernandes, Peter Siegel, Svetlana Komarova, et al.
CNS Neuroscience & Therapeutics|June 21, 2018
A cholecystokinin B receptor antagonist and cocaine interaction, phase I studyAhmed Elkashef, James Robert Brašić, Louis R Cantelina, et al.
Bioorganic & Medicinal Chemistry|June 2, 2009
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomographyYongjun Gao, Hayden T Ravert, Hiroto Kuwabara, et al.
NEJM Evidence|May 26, 2026
Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast CancerMark Clemons, Carol Stober, Gregory R Pond, et al.
Pageof 13